Supreme Court to Review Monsanto's Appeal in Roundup Cancer Lawsuits

The U.S. Supreme Court has agreed to hear an appeal from Bayer, the manufacturer of Roundup, as the company seeks to block thousands of state lawsuits alleging that the weedkiller causes cancer. The central issue is whether the Environmental Protection Agency's (EPA) approval of Roundup without a cancer warning preempts state-level claims.

Bayer, which acquired Roundup's original maker Monsanto in 2018, faces approximately 181,000 lawsuits, primarily from residential users. The case before the court originates from Missouri, where a man was awarded $1.25 million after developing non-Hodgkin's lymphoma, which he attributed to prolonged Roundup use.

The EPA maintains that glyphosate, Roundup's main ingredient, is not likely carcinogenic when used as directed. However, some studies have linked it to cancer. Bayer argues that compliance with federal labeling requirements should shield it from state lawsuits.

Environmental groups contend that Bayer's legal maneuver aims to prevent juries from hearing cases, as the company has faced significant losses in state courts. The Supreme Court's decision to hear this case follows conflicting lower court rulings and could have a substantial impact on the future use of glyphosate in U.S. agriculture.